In February 2008 the DHHS HIV treatment guidelines panel posted an updated (and separate) list of conflict-of-interest disclosures on its aidsinfo.nih.gov website which also reflects new disclosures for recent additions to the panel. Access it directly by clicking here.
Or view the ShillFactor annotated version immediately below.
(2008 membership)
Jean R. Anderson, MD Johns Hopkins University, Baltimore, MD Abbott Laboratories Speakers' Bureau; Honoraria Boehringer-Ingelheim Advisory Board GlaxoSmithKline Speakers' Bureau; Honoraria Pfizer/Agouron Advisory Board; Research support; Speakers' Bureau; Honoraria; Stock holder Thumbnail sketch Number of total drug/diagnostics companies receives money from: 4 Speakers bureau? (count): Yes; 3 Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): No
A. Cornelius Baker National Black Gay Men's Advocacy Coalition & Academy for Educational Development, Washington, DC Boehringer-Ingelheim Honoraria (Bristol-Myers Squibb Community Advisory Board) Gilead Sciences Grant/Program support Tibotec Grant/Program support Thumbnail sketch Number of total drug/diagnostics companies receives money from: 4 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
John G. Bartlett, MD (Co-chair with Dr. Clifford Lane, an NIH employee) Johns Hopkins University, Baltimore, MD Abbott Laboratories HIV Advisory Board Bristol-Myers Squibb HIV Advisory Board Gilead Sciences Research support GlaxoSmithKline HIV Advisory Board Pfizer HIV Advisory Board Tibotec HIV Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 6 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 3 (Medscape/WebMD, HIVeJournalClub/Boehringer Ingelheim, Clinical Issues in HIV Medicine/HIVMA--paid for with grants from Abbott Laboratories and Roche Pharmaceuticals) Remunerated writing/reporting for medical communications company not disclosed? (name): 3 (Medscape/WebMD, HIVeJournalClub/Boehringer Ingelheim,Correctional Medicine Institute/Gilead, HIV Management-The New York Course)
Charles Carpenter, MD Brown Medical School, Providence, RI Bristol-Myers Squibb Consultant Thumbnail sketch Number of total drug/diagnostics companies receives money from: 1 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
Judith S. Currier, MD (also on IAS-USA board of directors as well as HIVMA board) University of CaliforniaLos Angeles, Los Angeles, CA Achillion Pharmaceuticals DSMB Member Bristol-Myers Squibb Advisory Board; Honoraria Gilead Sciences Advisory Board GlaxoSmithKline Research support; Honoraria Koronis DSMB Member Merck Advisory Board; Research support Pfizer Advisory Board Schering Plough Research support Theratechnologies Research support Tibotec Advisory Board; Research support Vertex Research support Thumbnail sketch Number of total drug/diagnostics companies receives money from: 11 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 1 (Clinical Care Options HIV) Remunerated writing/reporting for medical communications company not disclosed? (name): 1 (Clinical Care Options)
Paul Dalton Director of Treatment Information and Advocacy, Project Inform, San Francisco, CA GlaxoSmithKline Community Advisory Board; Honoraria; Consultant Merck Community Advisory Board Napo Community Advisory Board Pfizer Community Advisory Board Tibotec Community Advisory Board; Consultant Tobira Community Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 6 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
Eric S. Daar, MD University of CaliforniaLos Angeles, Harbor-UCLA Medical Center, Los Angeles, CA Abbott Laboratories Advisory Board, Research Support, Speakers' Bureau, Honoraria, Consultant Boehringer-Ingelheim Advisory Board, Research Support, Speakers' Bureau, Honoraria, Consultant Bristol-Myers Squibb Advisory Board, Speakers' Bureau, Honoraria, Consultant Gilead Sciences Advisory Board, Research Support, Speakers' Bureau, Honoraria, Consultant GlaxoSmithKline Advisory Board, Research Support, Speakers' Bureau, Honoraria, Consultant Merck Advisory Board, Research Support, Speakers' Bureau, Honoraria, Consultant Monogram Biosciences Advisory Board, Speakers' Bureau, Honoraria, Consultant Pfizer Advisory Board, Speakers' Bureau, Honoraria, Consultant Tibotec Advisory Board, Speakers' Bureau, Honoraria, Consultant Thumbnail sketch Number of total drug/diagnostics companies receives money from: 9 Speakers bureau? (count): Yes; 9 Advisory board position at medical communications company not disclosed? (name): 1 (HIVeJournalClub/Boehringer Ingelheim) Remunerated writing/reporting for medical communications company not disclosed? (name): 6 (TheBody/TheBodyPro, Medscape/WedMD, Clinical Care Options, MedicineNet.com, HIVeJournalClub/Boehringer Ingelheim, HIV Management-The New York Course)
Steven G. Deeks, MD University of CaliforniaSan Francisco, San Francisco, CA Abbott Laboratories Advisory Board Boehringer-Ingelheim Advisory Board Bristol-Myers Squibb Advisory Board GlaxoSmithKline Advisory Board Merck Advisory Board; Research support Monogram Biosciences Advisory Board Pfizer DSMB member; Research support Roche Advisory Board Tibotec Advisory Board Trimeris Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 10 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
Carlos del Rio, MD (also on IAS-USA board of directorsas well as HIVMA board) Emory University, Atlanta, GA Abbott Laboratories Advisory Board Bristol-Myers Squibb Advisory Board Merck Advisory Board; Research support; Honoraria Roche Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: Speakers bureau? (count): Yes; 5 Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 3 (TheBody/TheBodyPro, Cases on the Web/IAS-USA, Medscape/WebMD)
Courtney V. Fletcher, PharmD University of Nebraska Medical Center, Omaha, NE Abbott Laboratories Advisory Board Bristol-Myers Squibb Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 2 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 4 (Clinical Care Options, CMEonHIV, Medscape/WebMD, HIV Management-The New York Course) Gerald H. Friedland, MD Yale University School of Medicine, New Haven, CT Abbott Laboratories Research Support Boehringer-Ingelheim Research Support Merck Research Support Thumbnail sketch Number of total drug/diagnostics companies receives money from: 3 (All are for research support) Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 1 (Cases on the Web/IAS-USA) Remunerated writing/reporting for medical communications company not disclosed? (name): 1 (Cases on the Web/IAS-USA) Joel E. Gallant, MD, MPH (also on IAS-USA board of directors) Johns Hopkins University, Baltimore, MD Abbott Laboratories DSMB member; Honoraria; Consultant Bristol-Myers Squibb Advisory Board Gilead Sciences Advisory Board; DSMB member; Research support; Honoraria GlaxoSmithKline Research support; Honoraria; Consultant Koronis DSMB member Merck Advisory Board; Research support Monogram Biosciences Honoraria Panocos Advisory Board Pfizer Advisory Board; Research support Roche Research support Schering Plough Advisory Board Tibotec Advisory Board, Research support; Honoraria Vertex Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 13 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 2 (Clinical Care Options HIV, TheBody) Remunerated writing/reporting for medical communications company not disclosed? (name): 5 (TheBody/TheBodyPro, Clinical Care Options, Hopkins HIV Guide, CM Institute/Gilead)
Roy M. Gulick, MD, MPH (also on IAS-USA board of directors) Weill Medical College of Cornell University, New York, NY Abbott Laboratories Consultant Boehringer-Ingelheim Consultant Bristol-Myers Squibb Consultant Gilead Sciences Research support; Consultant GlaxoSmithKline Consultant Koronis DSMB Chair Merck Research support; Consultant Monogram Biosciences Consultant Panacos Research support Pfizer Research support; Consultant Schering Plough Research support Trimeris Consultant Virco Consultant Thumbnail sketch Number of total drug/diagnostics companies receives money from: 13 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 5 (Clinical Care Options, Medscape/WedMD, Cases on the Web/IAS-USA, Stop HIV.us/University of Alabama School of Medicine/Division of Continuing Medical Education, HIV Management-The New York Course)
W. Keith Henry, MD University of Minnesota, Minneapolis, MN Bristol-Myers Squibb Research support; Speakers' Bureau Gilead Sciences Speakers' Bureau; Honoraria; Consultant GlaxoSmithKline Advisory Board; Research support; Speakers' Bureau; Honoraria; Consultant Pfizer Research support; Speakers' Bureau Roche Speakers' Bureau; Honoraria Serono Research support Theratechnologies Research support Tibotec Speakers' Bureau Research support; Speakers' Bureau Thumbnail sketch Number of total drug/diagnostics companies receives money from: 8 Speakers bureau? (count): Yes; 6 Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 2 (Clinical Care Options, TheBody/TheBodyPro)
Martin S. Hirsch, MD Massachusetts General Hospital and Harvard University, Boston, MA Merck DSMB Member TaiMed DSMB Member Thumbnail sketch Number of total drug/diagnostics companies receives money from: 2 (all for service on Data Safety Monitoring Board) Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 1 (HIV Management-The New York Course)
Morris Jackson Survivor & Treatment Activist, Center for Health Justice, Los Angeles, CA Gilead Sciences Consultant GlaxoSmithKline Summer Summit 2006 Merck Community Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 3 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
Wilbert Jordan, MD OASIS HIV Clinic & Charles R. Drew University of Medicine & Science, Los Angeles, CA Abbott Laboratories Advisory Board, Speakers' Bureau Boehringer-Ingelheim Advisory Board, Speakers' Bureau Bristol-Myers Squibb Advisory Board, Speakers' Bureau GlaxoSmithKline Advisory Board, Speakers' Bureau Roche Advisory Board, Speakers' Bureau Serono Advisory Board Tibotec Advisory Board, Speakers' Bureau Thumbnail sketch Number of total drug/diagnostics companies receives money from: 7 Speakers bureau? (count): 6 Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
H. Clifford Lane, MD (Co-chair with Johns Hopkins' Dr. John G. Bartlett) National Institutes of Health, Bethesda, MD Chiron/Novartis Research support, NIH patent on IL-2 licensed to Chiron/Novartis Thumbnail sketch Number of total drug/diagnostics companies receives money from: 1 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
Heidi M. Nass Outreach Specialist and Patient Advocate, UW Healths HIV Care Program, University of Wisconsin, Madison, WI Tibotec Community Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 1 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
James Neaton, PhD University of Minnesota, Minneapolis, MI Abbott Laboratories Research support Bristol-Myers Squibb Research support Chiron/Novartis Research support Gilead Sciences Research support GlaxoSmithKline Research support Merck Advisory Board, DSMB member, Consultant, Research support Thumbnail sketch Number of total drug/diagnostics companies receives money from: 6 (All but 1 is for research support) Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
Michael Saag, MD (also on IAS-USA board of directorsas well as HIVMA board) University of Alabama, Birmingham, AL Achillion Pharmaceuticals Grant/Research support Avexa Consultant Boehringer Ingelheim Grant/Research support; Consultant Bristol-Myers Squibb Consultant Gilead Sciences Grant/Research support; Consultant GlaxoSmithKline Grant/Research support; Consultant Merck Grant/Research support; Consultant Monogram Biosciences Consultant Panacos Grant/Research support; Consultant Pfizer Grant/Research support; Consultant Progenics Grant/Research support; Consultant Roche Grant/Research support; Consultant Serono Grant/Research support Tibotec Grant/Research support; Consultant Virco Consultant Thumbnail sketch Number of total drug/diagnostics companies receives money from: 15 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 2 (Cases on the Web/IAS-USA), UAB-School of Medicine/Division of Continuing Medical Education) Remunerated writing/reporting for medical communications company not disclosed? (name): 2 (Cases on the Web/IAS-USA), UAB-School of Medicine/Division of Continuing Medical Education)
Paul E. Sax, MD Harvard Medical School & Brigham and Womens Hospital, Boston, MA Abbott Laboratories Consultant, Speaking honoraria Bristol-Myers Squibb Consultant, Speaking honoraria Gilead Sciences Consultant, Speaking honoraria GlaxoSmithKline Consultant, Speaking honoraria, Grant support Merck Speaking honoraria Pfizer Grant support Tibotec Speaking honoraria Thumbnail sketch Number of total drug/diagnostics companies receives money from: 7 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 2 (Medscape/WedMD, Cases on the Web/IAS-USA) Remunerated writing/reporting for medical communications company not disclosed? (name): 6 (Clinical Care Options, Medscape/WebMD, HIVandHepatitis.com, CM Institute/Gilead Sciences, VirologyCME/Academy for Continued Healthcare Learning/accessCME.org, CMEonline/Harvard University School of Medicine)
Renslow Sherer, MD University of Chicago, Chicago, IL Abbott Laboratories Advisory Board; Speakers' Bureau; Honoraria; Consultant; Grant for CME program GlaxoSmithKline Advisory Board; Honoraria Johnson & Johnson Grant for health worker training Pfizer Grant for health worker training Tibotec Advisory Board; Honoraria Thumbnail sketch Number of total drug/diagnostics companies receives money from: 5 Speakers bureau? (count): Yes; 1 Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 4 (Medscape/WebMD, TheBody/TheBodyPro, VirologyCME/Academy for Continued Healthcare Learning/accessCME.org, HIV Management-The New York Course)
Paul Volberding, MD (also on IAS-USA board of directors) University of California, San Francisco & VA Medical Center, San Francisco, CA Bristol-Myers Squibb Advisory Board Gilead Sciences Advisory Board GlaxoSmithKline Advisory Board; Honoraria Pain Therapeutics, Inc. Scientific Advisory Board Pfizer Advisory Board PPD DSMB Schering Plough Advisory Board, Endpoints Adjudication Committee TaiMed Advisory Board Thumbnail sketch Number of total drug/diagnostics companies receives money from: 8 Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 1 (Cases on the Web/IAS-USA) Remunerated writing/reporting for medical communications company not disclosed? (name): 1 Cases on the Web/IAS-USA) Suzanne Willard, MD Elizabeth Glazer Pediatric AIDS Foundation, Washington DC Boehringer-Ingelheim Research support Thumbnail sketch Number of total drug/diagnostics companies receives money from: 1 (Research support only) Speakers bureau? (count): No Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 0
David A. Wohl, MD University of North Carolina, Chapel Hill, NC Abbott Laboratories Speakers' Bureau Boehringer-Ingelheim Speakers' Bureau Bristol-Myers Squibb Speakers' Bureau Gilead Sciences Speakers' Bureau Merck Research support, Speakers' Bureau Roche Research support, Speakers' Bureau Tibotec Speakers' Bureau Thumbnail sketch Number of total drug/diagnostics companies receives money from: 7 Speakers bureau? (count): Yes; 7 Advisory board position at medical communications company not disclosed? (name): 0 Remunerated writing/reporting for medical communications company not disclosed? (name): 7 (TheBody/TheBodyPro, Medscape/WebMD, Clinical Care Options, Correctional Medicine Institute/Gilead, FreeHIVinfo.com/Visionary Health Concepts, UNC-TV)
* Also a member of the AIDS Clinical Trials Group (ACTG) Executive Committee Also a member of the Adult ACTG Optimization of Antiretroviral Therapy (OpART) Committee Also a member of the International AIDS Society treatment guidelines committee § Also the chairperson of the Antiviral Advisory Committee of the Federal Drug Administration (FDA)
International AIDS Society-USA HIV Treatment Guidelines
(clinical practice guidelines from HIV medicine's largest professional association)
IAS-USA recently updated its treatment guidelines (August 2008). These updated disclosures will be forthcoming.
Disclosures for IAS Treatment Guidelines Panel, 2006 (source: www.jama.ama-assn.com)
Whereas the 2004 version (the most recent until now) of the IAS HIV/AIDS clinical practice guidelines did not require distinctions to be made between research/grant support and payments for advisory/consulting/speaking services or patents and equity ownership in pharmaceutical companies, this latest version does require these distinctions. Kudos to the JAMA editors, the American Medical Association, or outside inspectors/regulators for rendering these disclosures useful at last.
Scott M. Hammer, MD
Income for advisory services from:
Boehringer Ingelheim
ProgenicsPfizerTibotec-Virco/Johnson&JohnsonMargaret A. Fischl, MD
(Ms. Fischl reports commercial income from pharma research grants only.) Martin S. Hirsch, MD
Income for consulting services from:
Schering-Plough
David A. Katzenstein, MD Travel support and income for consulting services from:Abbott LaboratoriesBoehringer Ingelheim
Bristol-Myers Squibb
Gilead
Patent US 5,968,730 "PCR Assays for Monitoring Antiviral Therapy and Making Therapeutic Decisions in the Treatment of AIDS" (issued October 15, 1999)
Douglas D. Richman, MD
Income for consulting services from:Boehringer IngelheimBristol-Myers Squibb
Gilead
GlaxoSmithKline
IdenixMerck
Monogram Biosciences
Pfizer
Roche-Trimeris
Michael S. Saag, MD Income for advisory services from:AchillionBoehringer IngelheimBristol-Myers Squib
Gilead
GlaxoSmithKlineMonogram Biosciences
PanacosPfizer/Agouron
ProgenicsRocheTanoxTibotec-Virco/Johnson&JohnsonTrimeris
Vertex
Robert T. Chip Schooley, MD
Stock options in:
Monogram BiosciencesIncome for consulting services from:Abbott Laboratories
Bristol-Myers Squibb
Gilead
GlaxoSmithKline
Merck
Monogram Biosciences
Roche
Tibotec-Virco/Johnson&Johnson
VertexIncome for scientific advisory services from:Abbott Laboratories
Bristol-Myers Squibb
Gilead
GlaxoSmithKline
Merck
Monogram Biosciences
Roche
Tibotec-Virco/Johnson&Johnson
Vertex Melanie A. Thompson, MD Income for advisory services from:Abbott LaboratoriesGlaxoSmithKlineGileadPfizer/AgouronSeronoTibotec-Vircoc/Johnson&JohnsonTriangle
Honoraria income from:Abbott LaboratoriesBoehringer IngelheimBristol-Myers SquibbGlaxoSmithKlineGileadPfizer/AgouronRocheSeronoTibotec-Virco/Johnson&JohnsonTriangleTrimerisPaul A. Volberding, MD
Stock options in:Immune Response Corp.Income for advisory services from:
Bristol-Myers Squibb
MerckScheringGlaxoSmithKlinePfizerHonoraria income from:GileadVertex Charles C.J. Carpenter, MDNo relevant financial affiliations to discloseNB: While financial disclosures for non-US panel members are included in JAMA paper and largely reflect those listed above for the US domiciled physicians, they are not included here. They are: Mauro Schecter (Brazil), Julio Montaner (Canada), Brian Gazzard (United Kingdom), Jose Gatell (Spain), Stefano Vella (Italy) and Patrick Yeni (France).
NOTE: While the concerns of commercial bias, corruption and kick-backs expressed here are serious and well-documented, they in no way endorse or support a thesis which denies any of the following:
(1) That HIV is necessary in the causation of the immune deficiency syndrome called AIDS; (2) That HIV antibody tests accurately diagnose HIV in up to 98% of infected individuals after 4-12 weeks of infection; (3) That antiretroviral medicines, while far from perfect, improve immune function and can extend life; (4) That HIV is heterosexually as well as homosexually transmitted; (5) That condoms, when used properly, can prevent HIV transmission; (6) That HIV/AIDS is one of many serious public health challenges in many regions of Africa, Asia, and the Caribbean.
